Cefiderocol and Ampicillin-sulbactam vs. Colistin +/- Meropenem for Carbapenem Resistant A. Baumannii

Clinical trial NCT05922124 · RECRUITING

Trial details

NCT number: NCT05922124
Sponsor: Rambam Health Care Campus
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Carbapenem Resistant Bacterial Infection Acinetobacter Bacteremia Acinetobacter Pneumonia

Start date: 2024-09-01
Primary completion: 2026-07-01
Enrollment: 734

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.